Interactions Between Neuropsychiatric Symptoms and Alzheimer's Disease Neuroimaging Biomarkers in Predicting Longitudinal Cognitive Decline
Objective To examine interactions between Neuropsychiatric symptoms (NPS) with Pittsburgh Compound B (PiB) and fluorodeoxyglucose positron emission tomography (FDG‐PET) in predicting cognitive trajectories. Methods We conducted a longitudinal study in the setting of the population‐based Mayo Clinic...
Main Authors: | Anna Pink, Janina Krell‐Roesch, Jeremy A. Syrjanen, Luke R. Christenson, Val J. Lowe, Prashanthi Vemuri, Julie A. Fields, Gorazd B. Stokin, Walter K. Kremers, Eugene L. Scharf, Clifford R. Jack Jr., David S. Knopman, Ronald C. Petersen, Maria Vassilaki, Yonas E. Geda |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-03-01
|
Series: | Psychiatric Research and Clinical Practice |
Online Access: | https://doi.org/10.1176/appi.prcp.20220036 |
Similar Items
-
Plasma‐derived biomarkers of Alzheimer's disease and neuropsychiatric symptoms: A community‐based study
by: Janina Krell‐Roesch, et al.
Published: (2023-07-01) -
Association between physical activity and longitudinal change in body mass index in middle-aged and older adults
by: Laura Cleven, et al.
Published: (2023-01-01) -
Area Deprivation Index as a Surrogate of Resilience in Aging and Dementia
by: Maria Vassilaki, et al.
Published: (2022-06-01) -
Sex-difference in the association between social drinking, structural brain aging and cognitive function in older individuals free of cognitive impairment
by: Osama A. Abulseoud, et al.
Published: (2024-04-01) -
Clinical Neurophysiology, Neuroimaging, and Neuromodulation of Neuropsychiatric Disorders
by: Yoshihiro Noda
Published: (2021-11-01)